Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome

(2014) C. Agostinis et al.   BLOOD

New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies

(2014) Cecilia Beatrice Chighizola et al.   Current Rheumatology Reports

Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

(2013) Vijaya Murthy et al.   ARTHRITIS AND RHEUMATISM

Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system

(2013) R. Tozzoli et al.   AUTOIMMUNITY REVIEWS

Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus

(2013) E. AKHTER et al.   JOURNAL OF RHEUMATOLOGY

Antiphospholipid antibody profiling — Time for a new technical approach?

(2012) Dirk Roggenbuck et al.   AUTOIMMUNITY REVIEWS

Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome

(2012) Michael Mahler et al.   AUTOIMMUNITY REVIEWS

What Have We Learned about Antiphospholipid Syndrome from Patients and Antiphospholipid Carrier Cohorts?

(2012) Vittorio Pengo et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

β2-Glycoprotein I: evolution, structure and function

(2011) P. G. DE GROOT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

(2011) Pier Luigi Meroni et al.   Nature Reviews Rheumatology

Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

(2011) A. Banzato et al.   THROMBOSIS RESEARCH

Anti- 2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?

(2010) L. Andreoli et al.   ANNALS OF THE RHEUMATIC DISEASES

Update of the guidelines for lupus anticoagulant detection

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study

(2009) B. DE LAAT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS